534 related articles for article (PubMed ID: 32803228)
1. Immunosuppressive Agents and Infectious Risk in Transplantation: Managing the "Net State of Immunosuppression".
Roberts MB; Fishman JA
Clin Infect Dis; 2021 Oct; 73(7):e1302-e1317. PubMed ID: 32803228
[TBL] [Abstract][Full Text] [Related]
2. Opportunistic infections--coming to the limits of immunosuppression?
Fishman JA
Cold Spring Harb Perspect Med; 2013 Oct; 3(10):a015669. PubMed ID: 24086067
[TBL] [Abstract][Full Text] [Related]
3. [Pulmonary infections following solid organ transplantation].
Müller V; Kováts Z; Horváth G
Orv Hetil; 2012 Jun; 153(23):899-903. PubMed ID: 22668590
[TBL] [Abstract][Full Text] [Related]
4. [Infectious complications due to immunosuppression in organ transplant patients].
Morelon E; Touraine JL
Rev Prat; 2007 Oct; 57(15):1677-86. PubMed ID: 18080426
[TBL] [Abstract][Full Text] [Related]
5. Immunosuppression in solid organ-transplant recipients and impact on nutrition support.
Wilson NK; Kataria AD
Nutr Clin Pract; 2024 Feb; 39(1):109-116. PubMed ID: 38030572
[TBL] [Abstract][Full Text] [Related]
6. Immunosuppressive drugs and associated complications in abdominal organ transplantation.
Olson JC
Curr Opin Crit Care; 2022 Apr; 28(2):208-215. PubMed ID: 35142726
[TBL] [Abstract][Full Text] [Related]
7. New immunosuppressive strategies and the risk of infection.
Mueller NJ
Transpl Infect Dis; 2008 Dec; 10(6):379-84. PubMed ID: 18811628
[TBL] [Abstract][Full Text] [Related]
8. Graft rejection after immune checkpoint inhibitor therapy in solid organ transplant recipients.
Smedman TM; Line PD; Guren TK; Dueland S
Acta Oncol; 2018 Oct; 57(10):1414-1418. PubMed ID: 29912605
[No Abstract] [Full Text] [Related]
9. Infections after organ transplantation and immune response.
Elalouf A
Transpl Immunol; 2023 Apr; 77():101798. PubMed ID: 36731780
[TBL] [Abstract][Full Text] [Related]
10. Prevention and treatment of infectious complications after solid organ transplantation in children.
Allen U; Green M
Pediatr Clin North Am; 2010 Apr; 57(2):459-79, table of contents. PubMed ID: 20371047
[TBL] [Abstract][Full Text] [Related]
11. Withdrawal of immunosuppression: implications for composite tissue allograft transplantation.
Hricik DE
Transplant Proc; 1998 Sep; 30(6):2721-3. PubMed ID: 9745554
[TBL] [Abstract][Full Text] [Related]
12. Evolving immunosuppressive regimens for lung transplant recipients.
Meyer NJ; Bhorade SM
Semin Respir Crit Care Med; 2006 Oct; 27(5):470-9. PubMed ID: 17072795
[TBL] [Abstract][Full Text] [Related]
13. Opportunistic infections complicating solid organ transplantation with alemtuzumab induction.
Helfrich M; Ison MG
Transpl Infect Dis; 2015 Oct; 17(5):627-36. PubMed ID: 26228653
[TBL] [Abstract][Full Text] [Related]
14. Association between elevated whole blood Epstein-Barr virus (EBV)-encoded RNA EBV polymerase chain reaction and reduced incidence of acute lung allograft rejection.
Ahya VN; Douglas LP; Andreadis C; Arnoldi S; Svoboda J; Kotloff RM; Hadjiliadis D; Sager JS; Woo YJ; Pochettino A; Schuster SJ; Stadtmauer EA; Tsai DE
J Heart Lung Transplant; 2007 Aug; 26(8):839-44. PubMed ID: 17692789
[TBL] [Abstract][Full Text] [Related]
15. Immunosuppression following organ transplantation. Part 1: mechanisms and immunosuppressive agents.
Cajanding R
Br J Nurs; 2018 Sep; 27(16):920-927. PubMed ID: 30187798
[TBL] [Abstract][Full Text] [Related]
16. Immune function as predictor of infectious complications and clinical outcome in patients undergoing solid organ transplantation (the ImmuneMo:SOT study): a prospective non-interventional observational trial.
Drabe CH; Sørensen SS; Rasmussen A; Perch M; Gustafsson F; Rezahosseini O; Lundgren JD; Ostrowski SR; Nielsen SD
BMC Infect Dis; 2019 Jul; 19(1):573. PubMed ID: 31269923
[TBL] [Abstract][Full Text] [Related]
17. Transplant-related immunosuppression: a review of immunosuppression and pulmonary infections.
Duncan MD; Wilkes DS
Proc Am Thorac Soc; 2005; 2(5):449-55. PubMed ID: 16322599
[TBL] [Abstract][Full Text] [Related]
18. Urinary tract infections after renal transplantation.
Schmaldienst S; Dittrich E; Hörl WH
Curr Opin Urol; 2002 Mar; 12(2):125-30. PubMed ID: 11859258
[TBL] [Abstract][Full Text] [Related]
19. [Cytomegalovirus infection after solid-organ transplantation, its risk factors, direct and indirect effects and prevention strategies].
Varga M; Remport A; Czebe K; Péter A; Toronyi E; Sárváry E; Fehérvári I; Sulyok B; Járay J
Orv Hetil; 2008 Mar; 149(12):551-8. PubMed ID: 18343771
[TBL] [Abstract][Full Text] [Related]
20. Opportunistic Infections After Induction With Alemtuzumab or Basiliximab: A 3-Year Kidney Transplantation Experience.
Florescu DF; Seaman JA; Kalil AC; Qiu F; Bremers D; Westphal SG
Transplant Proc; 2021 Apr; 53(3):1058-1063. PubMed ID: 32921434
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
